Application process for Venture Leaders Biotech Program 2024 is now open

The Venture Leaders Biotech Program offers entrepreneurs a way to accelerate the growth curve of their startups by taking them to one of the most significant hubs of technological innovation in the life sciences: Boston.

The program, which is free of charge, is a unique opportunity for top Swiss-based biotech startups to assert their presence on the international stage while expanding their U.S. network. For one week in May, the Venture Leaders will have the opportunity to meet with investors and profit from the experience and insights of industry experts, VCs, and peers.

Alumni of the program include Covagen (acquired by Johnson&Johnson), Redbiotec (partly acquired by Pfizer), KB Medical (acquired by Globus Medical), SimplicityBio (acquired by Precision for Medicine), AMAL Therapeutics (acquired by Boehringer Ingelheim) and Interax Biotech (Seed round with US investors met during the roadshow).

You may want to explore: Mckinsey & Company Next Generation Women Leaders (NGWL) EMEA Program 2024

Benefits of Venture Leaders Biotech Program

• Win Your place in Swiss National Startup Team 2024 and meet industry leaders and international biotech investors  in Boston.

You should check out: Exploring the HISA Youth Dialogue 2024 | Fully Funded Conference Experience in Hungary

Eligibility

• Open to founding and managing members of biotech-based Swiss startups:
•  Ready to expand their businesses in the US with the support of international investors:
• development of a global biotech startup:
• Mandatory to be incorporated before the Roadshow starts.

It might catch your attention to investigate: International AIDS Conference 2024 in Germany (Fully Funded)

Application for Venture Leaders Biotech Program

Register your project and apply for one of the 10 seats in the intensive entrepreneurship week training program in global innovation hubs.

Registration deadline: 26/02/2024

You might find it worthwhile to investigate: ENJ Reporting on Fisheries in Belize, Honduras, Guatemala and Mexico (Fully Funded)